（「本公司」） 薪酬委員會 4. 薪酬委員會每年須召開會議至少一次；倘因工作需要，薪酬委員會應召開額外會議。 5. 薪酬委員會主席可自行決定召開額外會議。 6. 會議法定人數為薪酬委員會之三名成員，且大多數成員應為獨立非執行董事。 7. 薪酬委員會可不時邀請顧問（包括但不限於外聘顧問）出席會議向成員提供意見。 8. 一項經薪酬委員會全體成員簽署的書面決議案，應視為有效及有作用，猶如該決議案 是在一次妥為召開及舉行的薪酬委員會會議上通過一樣，而有關決議案可由一式多 份，每份由一名或多於一名薪酬委員會成員簽署的文件組成。 9. 薪酬委員會成員須親自或透過電訊方式，包括但不限於電話或視頻會議，或能讓所有 與會人士互相聆聽的類似通訊設備參加薪酬委員會會議。 10. 薪酬委員會會議之議事程序受本公司細則第 126 條所規管。 職責、權力及職能 之 職權範圍 成員 會議次數及議事程序 1 1. 薪酬委員會由董事會（「董事會」）不時委任不少於三名成員組成，且大多數成員應 為獨立非執行董事。 2. 董事會須提名其中一名獨立非執行董事（「獨立非執行董事」）為薪酬委員會主席。 3. 本公司之公司秘書應為薪酬委員會之秘書。 2 1 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 天安卓健有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00383 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 | 本月底法定/註冊股本總額： HKD 300,000,0 ...

"深圳不仅是十五运会和残特奥会闭幕式的举办地，还承接了广东赛区约20%的十五运会竞技比赛和残 特奥会项目，赛事频密且点多面广，覆盖全市9个区。"邓世聪认真地说道，"我们在传统人巡技防基础 上，创新运用'全电鸿+量子通信'智慧保电系统，可以有效提升保电效率。" 在残特奥会自行车赛场，配电房里的关键供电设备都装有数字化监测终端，实时监测设备温度和负荷变 化。而这些小小的"智慧哨兵"之所以能发挥大作用，其秘诀就在于电鸿。 "电鸿是南方电网公司基于开源'鸿蒙'与开源'欧拉'基础上自主研发的行业首款电力物联操作系统。它像 幕后'大脑'，指挥'智慧哨兵'交互协作，又像是为不同类型的'智慧哨兵'装上'通用语言翻译器'，实现数 据互联互通。"深圳供电局十五运会保电办保电系统建设组副组长王程斯介绍道，深圳供电局正对各级 保电设备和场所的两千个监测终端安装电鸿系统，这是电鸿在国内大型活动电力保障中首次大规模实战 部署，让供电人员对每座场馆，都能够从220伏插座"一路"监测到相关联的500千伏高压设备运行状态。 "我们正在构筑一条从电力调度中枢到重要赛会场馆全链路的量子加密通信线路，通过通信与加密设备 一体的前沿技术，实现对现有通 ...

Company News - China Railway Construction (01186.HK) reported a new contract amount of approximately 1,056.17 billion yuan for the first half of the year, a year-on-year decrease of 4.04% [2] - China Metallurgical Group (01618.HK) announced a new contract amount of 548.2 billion yuan for the first half of the year, down 19.1% year-on-year [2] - Sichuan Chengyu Expressway (00107.HK) won the bid for the G5 Jingkun Expressway Chengdu to Ya'an section expansion project, with a total investment of approximately 28.548 billion yuan [2] - Road King Infrastructure (01098.HK) reported total property sales of 5.232 billion yuan for the first half of the year, a decrease of 28.37% year-on-year [2] - Amax Holdings (00880.HK) plans to acquire a property in Hengqin for 724.2 million yuan to diversify its business portfolio [2] - Chaoyue Eye Hospital (02219.HK) signed a construction contract for the first phase of its comprehensive medical facility project, with a contract value of 223 million yuan [2] - Bay Area Development (00737.HK) reported total toll revenue of 243 million yuan for June, a year-on-year decrease of 4% [2] - Decent Pharmaceuticals-B (06996.HK) received approval for its drug, Hivio®, for the second-line treatment of multiple myeloma in China [2] - Tianchen Holdings (01201.HK) plans to invest 30 million yuan to establish a joint venture in Shenzhen for new energy heavy truck charging stations [2] Performance Summary - WuXi AppTec (02359.HK) reported mid-year revenue of 20.799 billion yuan, a year-on-year increase of 20.64%, and a net profit of 8.561 billion yuan, up 101.92% year-on-year [3] Earnings Announcements - China Nonferrous Mining (01258.HK) issued a profit warning, expecting mid-term net profit of approximately 258 million USD, a year-on-year increase of about 18% [4] - Hualing Pharmaceutical-B (02552.HK) issued a profit warning, expecting mid-term net profit of approximately 1.184 billion yuan, turning from loss to profit [4] - Little Yellow Duck (02250.HK) issued a profit warning, expecting mid-term revenue to increase by over 30% year-on-year [4] - Qingci Games (06633.HK) issued a profit warning, expecting mid-term net profit to increase by approximately 78%-130% year-on-year [4] - Goodbaby International (01086.HK) issued a profit warning, expecting mid-term net profit to decrease by approximately 40%-50% year-on-year [4] - Qianhai Health (00911.HK) issued a profit warning, expecting mid-term net profit to decrease by approximately 60%-70% year-on-year [4] - Tianan Health (00383.HK) issued a profit warning, expecting mid-term net profit to decrease to approximately 7 million to 17 million HKD [4] - Pacific Network (00543.HK) issued a profit warning, expecting mid-term net loss of approximately 5 million to 15 million yuan [4] Buyback and Increase Dynamics - HSBC Holdings (00005.HK) repurchased 348,700 shares for approximately 35.487 million HKD at a price of 101.4-102 HKD [3] - China Eastern Airlines (00670.HK) repurchased 2.5 million shares for approximately 7.4983 million HKD at a price of 2.97-3.03 HKD [3] - Founder Holdings (00418.HK) canceled a total of 17.9962 million shares that had been repurchased [3]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 MEDICARE （於百慕達註冊成立之有限公司） （股份代號：383） 盈利警告 股東及潛在投資者買賣本公司證券時，務請審慎行事。 代表董事會 天安卓健有限公司 執行董事 江木賢 香港，二零二五年七月二十八日 於本公佈日期，董事會包括執行董事江木賢先生、郭美保先生及周海英先生；非執行董事李成輝 先生（主席）、王大鈞先生、高兆元先生及張園園女士；及獨立非執行董事夏曉寧博士、王永權 博士、楊麗琛女士及曹丹先生。 –2– 本公佈乃由天安卓健有限公司（「本公司」，連同其附屬公司統稱「本集團」）根據 香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條及香港法例 第571章證券及期貨條例第X IVA部項下之內幕消息條文（定義見上市規則）而作 出。 本公司董事會（「董事會」）謹此通知本公司股東（「股東」）及潛在投資者，根據其 對本集團截至二零二五年六月三十日止六個月之相關未經審核綜合管理賬目 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 MEDICARE （於百慕達註冊成立之有限公司） （股份代號：383） 本公司希望就供股所得款項用途之變更及預期使用時間表提供進一步詳情。 於本公司進行供股之時，由於並無具備商業可行條款的長期融資，故有需要為昆 明醫院二期項目的發展籌集資金。自供股完成時起至二零二四年二月初，昆明醫 院二期項目發展的長期融資並無重大發展。 於二零二四年二月七日，雲南省自然資源廳發佈《關於加強土地要素保障支持民營 經濟高質量發展的實施意見》的通知（「通知」），其中，該部門旨在改善政府事 務，為民營企業利用其房地產創造一個充滿活力的環境，並建議(i)改善房地產登 記服務的質量和效率，包括簡化抵押登記的網上審批和所需時間；以及(ii)加強政 –1– 策落實，特別是優化營商環境，營造公平、公正及公開的土地市場環境，鼓勵民 營資本進入土地市場，加強便利民營企業的服務。於二零二四年四月三日，雲南 省衛生健康委發佈《關於印發雲南省「十 ...

Company Overview - Tian An Medicare, formerly known as China Medical & Health Care Group Limited, was listed on the Hong Kong Stock Exchange in August 1991 and rebranded in May 2024 to better reflect its new vision and development strategy [3][4] - The company is transitioning from an investment holding group to a provider of integrated medical and elderly care services, focusing on investment, management, and operation within the medical and elderly care industries [4] Financial Performance - As of December 31, 2024, Tian An Medicare reported total revenue of 1.489 billion yuan, a year-on-year increase of 0.32%, and a net profit attributable to shareholders of 26.6449 million yuan, reflecting a significant year-on-year growth of 96.03% [2] - The company's asset-liability ratio stands at 46.46% [2] Stock Performance - Over the past month, Tian An Medicare has seen a cumulative increase of 2.5%, while year-to-date, the stock has risen by 15.41%, underperforming the Hang Seng Index, which has increased by 25.27% [2] - The stock closed at 0.9 HKD per share on July 23, with a daily increase of 9.76% and a trading volume of 20,000 shares [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -1.96 times, with a median of 1.36 times. Tian An Medicare's P/E ratio is 30.86 times, ranking 41st in the industry [3] - Comparatively, other companies in the sector have significantly lower P/E ratios, such as Giant Medical Holdings at 0.33 times and Jingjiu Health at 0.38 times [3] Strategic Direction - The company aims to establish a regional medical and elderly care service network in China and the Asia-Pacific region, providing integrated services from basic community healthcare to advanced medical and elderly care [4] - Tian An Medicare is actively pursuing partnerships in China and the Asia-Pacific region to expand its business coverage and service categories, with ongoing projects aimed at improving operational efficiency and customer service [4]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 董事會會議召開日期 薛寶鈴 香港，二零二五年七月二十二日 於本公佈日期，董事會由執行董事江木賢先生、郭美保先生及周海英先生；非執行董事李成輝先生 （主席）、王大鈞先生、高兆元先生及張園園女士；以及獨立非執行董事夏曉寧博士、王永權博士、 楊麗琛女士及曹丹先生組成。 天安卓健有限公司（「本公司」）董事會（「董事會」）謹此公佈，本公司將於二零二五 年八月一日（星期五）舉行董事會會議，藉以（其中包括）批准本公司及其附屬公司 截至二零二五年六月三十日止六個月之中期業績及其刊發，以及考慮派發中期股息 （如有）。 承董事會命 天安卓健有限公司 公司秘書 ...

Group 1 - The core viewpoint of the news is that Tian An Medicare is transitioning from an investment holding group to a provider of integrated medical and elderly care services, focusing on expanding its business in China and the Asia-Pacific region [3] - As of July 2, the stock price of Tian An Medicare rose by 40.74% to HKD 1.14 per share, with a trading volume of 165,000 shares and a turnover of HKD 156,800, indicating significant market interest [1] - Financial data shows that for the year ending December 31, 2024, Tian An Medicare achieved total revenue of CNY 1.489 billion, a year-on-year increase of 0.32%, and a net profit attributable to shareholders of CNY 26.6449 million, a substantial increase of 96.03% [1] Group 2 - Currently, there are no institutional investment ratings for Tian An Medicare, and its price-to-earnings (P/E) ratio stands at 30.49, ranking 38th in the healthcare equipment and services industry, which has an average P/E ratio of -3.47 [2] - The company is fully owned by Tongren Medical Industry Group and has several operational institutions, including Nanjing Tongren Hospital and Kunming Tongren Hospital, employing nearly 2,100 staff [3] - The company is actively pursuing various cooperation projects with partners in China and the Asia-Pacific region to diversify its business model and enhance its service offerings [3]

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 00383 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | ...